PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Transfemoral implantation • Transapical implantation PART 07: Reimbursement and economics of transcatheter mitral valve replacement in US • Reimbursement for transcatheter mitral valve replacement • Economic impact of transcatheter mitral valve replacement PART 08: Geographical segmentation • Transcatheter mitral valve replacement market in Americas • Transcatheter mitral valve replacement market in EMEA • Transcatheter mitral valve replacement market in APAC PART 09: Market drivers • Prevalence of mitral regurgitation • Use of minimally invasive procedures • Use of transcatheter mitral valve replacement in high-risk individuals PART 10: Impact of drivers PART 11: Market challenges • Availability of alternative treatment • Stringent regulatory framework • Lack of skilled personnel PART 12: Impact of drivers and challenges PART 13: Market trends • Development of novel products • Increase in M&A • Focus on US PART 14: Vendor landscape • Competitive scenario • Product portfolio matrix PART 15: Key vendor analysis • Abbott Laboratories • Edwards Lifesciences • Micro Interventional Devices • Neovasc • Other prominent vendors PART 16: Appendix • List of abbreviations PART 17: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Global transcatheter mitral valve replacement market 2015-2020 ($ billions) Exhibit 03: Five forces analysis Exhibit 04: Global transcatheter mitral valve replacement market segmentation by product Exhibit 05: Comparison of transfemoral and transapical implantation Exhibit 06: Global transcatheter mitral valve replacement market segmentation by geography 2015 Exhibit 07: Global transcatheter mitral valve replacement market segmentation by geography 2020 Exhibit 08: Global transcatheter mitral valve replacement market segmentation by geography 2015-2020 Exhibit 09: Transcatheter mitral valve replacement market in Americas 2015-2020 ($ millions) Exhibit 10: Transcatheter mitral valve replacement market in EMEA 2015-2020 ($ millions) Exhibit 11: Transcatheter mitral valve replacement market in APAC 2015-2020 ($ millions) Exhibit 12: Impact of drivers Exhibit 13: Impact of drivers and challenges Exhibit 14: Major acquisitions 2015 Exhibit 15: Products of few vendors 2015 Exhibit 16: Abbott Laboratories: Key takeaways Exhibit 17: Edwards Lifesciences: Business segmentation by revenue 2014 Exhibit 18: Edwards Lifesciences: Business segmentation by revenue 2013 and 2014 ($ billions) Exhibit 19: Edwards Lifesciences: Key takeaways Exhibit 20: Micro Interventional Devices: Key takeaways Exhibit 21: Neovasc: Geographical segmentation by revenue 2014 Exhibit 22: Neovasc: Key takeaways Exhibit 23: Other vendors Exhibit 24: Emerging vendors

Abbott Laboratories, Edwards Lifesciences, Micro Interventional Devices, Neovasc, MitrAssist, NaviGate Cardiac Structures, Valtech.